159 related articles for article (PubMed ID: 2442741)
1. Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat.
Wisner JR; Renner IG; Grendell JH; Niederau C; Ferrell LD
Pancreas; 1987; 2(2):181-6. PubMed ID: 2442741
[TBL] [Abstract][Full Text] [Related]
2. Protection by gabexate mesilate (FOY) of the exocrine pancreas in rats with acute pancreatitis induced by a supramaximal dose of caerulein.
Hirano T; Manabe T; Tobe T
J Gastroenterol Hepatol; 1991; 6(3):260-4. PubMed ID: 1717033
[TBL] [Abstract][Full Text] [Related]
3. Esterase inhibitors prevent lysosomal enzyme redistribution in two noninvasive models of experimental pancreatitis.
Ohshio G; Saluja AK; Leli U; Sengupta A; Steer ML
Gastroenterology; 1989 Mar; 96(3):853-9. PubMed ID: 2464526
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
Freise J
Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of gabexate mesilate on acute pancreatitis induced by tacrolimus (FK-506) in rats in which the pancreas was stimulated by caerulein.
Ito T; Kimura T; Furukawa M; Yamaguchi H; Goto M; Nakano I; Nawata H
J Gastroenterol; 1994 Jun; 29(3):305-13. PubMed ID: 7520321
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of gabexate mesilate (FOY) against impaired pancreatic energy metabolism in rat acute pancreatitis induced by caerulein.
Hirano T; Manabe T; Tobe T
Life Sci; 1991; 49(22):PL179-84. PubMed ID: 1719326
[TBL] [Abstract][Full Text] [Related]
7. The effects of nafamostat mesilate (FUT-175) on caerulein-induced acute pancreatitis in the rat.
Wisner JR; Ozawa S; Renner IG
Int J Pancreatol; 1989 May; 4(4):383-90. PubMed ID: 2732529
[TBL] [Abstract][Full Text] [Related]
8. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
Dabrowski A; Gabryelewicz A
J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457
[TBL] [Abstract][Full Text] [Related]
9. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models.
Lankisch PG; Pohl U; Göke B; Otto J; Wereszczynska-Siemiatkowska U; Gröne HJ; Rahlf G
Gastroenterology; 1989 Jan; 96(1):193-9. PubMed ID: 2909420
[TBL] [Abstract][Full Text] [Related]
10. Controlled trial of protease inhibitor gabexelate mesilate (FOY) in the treatment of acute pancreatitis.
Yang CY; Chang-Chien CS; Liaw YF
Pancreas; 1987; 2(6):698-700. PubMed ID: 3125546
[TBL] [Abstract][Full Text] [Related]
11. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
Freise J; Melzer P; Schmidt FW; Horbach L
Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
[TBL] [Abstract][Full Text] [Related]
12. Effect of methylcarbonylmethyl 2(S)-[4-(4-guanidino-benzoyloxy)phenyl] propionate methanesulfonate (TT-S24) on experimental pancreatitis in rats.
Tagami H; Abe S; Yoshida Y; Tanaka I; Kamei C
Biol Pharm Bull; 1998 Mar; 21(3):227-30. PubMed ID: 9556150
[TBL] [Abstract][Full Text] [Related]
13. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
Hirano T; Manabe T; Tobe T
Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial with a protease inhibitor gabexate mesilate in acute pancreatitis.
Harada H; Miyake H; Ochi K; Tanaka J; Kimura I
Int J Pancreatol; 1991; 9():75-9. PubMed ID: 1744450
[TBL] [Abstract][Full Text] [Related]
15. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
Freise J; Schmidt FW; Magerstedt P; Schmid K
Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
[TBL] [Abstract][Full Text] [Related]
16. General and selective inhibition of pancreatic enzyme discharge using a proteinase inhibitor (FOY-305).
Adler G; Rausch U; Weidenbach F; Arnold R; Kern HF
Klin Wochenschr; 1984 May; 62(9):406-11. PubMed ID: 6202931
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis with an extract of Artemisia asiatica attenuates the severity of cerulein-induced pancreatitis in rats.
Hahm KB; Kim JH; You BM; Kim YS; Cho SW; Yim H; Ahn BO; Kim WB
Pancreas; 1998 Aug; 17(2):153-7. PubMed ID: 9700946
[TBL] [Abstract][Full Text] [Related]
18. [Protective effect of camostat mesilate and allopurinol in acute edematous pancreatitis in the rat induced by excessive doses of caerulein].
Yamasaki Y; Kuroshima T; Tsuji K; Kawamoto H; Higashimoto Y
Nihon Shokakibyo Gakkai Zasshi; 1987 Jul; 84(7):1498. PubMed ID: 3682249
[No Abstract] [Full Text] [Related]
19. Protective effect of gabexate mesilate (FOY) against pancreatic injuries induced by ethanol in rats.
Hirano T
Nihon Geka Hokan; 1994 Jan; 63(1):10-20. PubMed ID: 7826181
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
